Pondering vexing issues in infection prevention and control
Showing posts with label silvia munoz-price. Show all posts
Showing posts with label silvia munoz-price. Show all posts
Monday, May 2, 2016
The importance of considering time when evaluating risks of base jumping (and maybe even antibiotics)
This is a guest post by L. Silvia Munoz-Price, MD, PhD. Associate Professor of Medicine at the Medical College of Wisconsin. Enterprise Epidemiologist at Froedtert Health. Milwaukee.
Over a month ago, Eli asked me to write this piece to discuss my recent CID paper on handling time dependent variables. I knew this had to be done with an analogy but after several weeks of mulling over this, I was still uncertain on how to colloquially explain this concept to you. So, as I was almost ready to forget about this post while on a plane to Miami, I had sudden inspiration as I was about to nap! I really hope this helps everyone understand this statistical concept. If not, then I'm not sure reading the CID paper will help you much either…stick to 2x2 tables (sorry!!).
Setting: Let’s imagine Eli and his wife invited my hubby and me to go base jumping in New Zealand for a week (See figure…Eli take note!!). So, now let’s observe our jumping habits: of course, I would jump once and be done with it for lifetime. My hubby would probably not jump at all and just enjoy watching crazy people jump. Let’s say Eli decides to jump every day (two days he jumps twice!) and his wife jumps three consecutive days.
Study design: Ok. Not to be morbid, but the easiest outcome to evaluate is mortality (binary variable; 1: dead or 0:alive) by the end of the vacation. The exposure variable of interest is base jumping.
Option 1: The easiest way to look at this association is to construct a 2x2 table: Did you jump? (yes/no) Did you die? (yes/no). See, the problem with this analysis is that it ignores the intensity of the exposure as Eli, his wife, and I would be considered as a “yes” and only my husband would be a “no”. But, is it reasonable to analyze the exposures for Eli, his wife and I the same way? Intuitively, we probably could say no.
Option 2: A tad more elaborate way to look at this would be to count the number of jumps per person and enter these numbers in the analysis. So, Eli would have 9, his wife would have 3, I would have 1, and my husband would have 0. What is the problem with this approach? Well, it completely disregards time of exposures, correct? It is like having all those jumps in only one day. We need to ask: when was “that” day that all those exposures got summed? Was it at the beginning of the week or towards the end? Did the outcome happen at the beginning of the week, in the middle or at the end? Is it reasonable to analyze all those jumps clustered in time within a single day? Intuitively, I would say no. A similar problem happens with number of days that jumps occurred, especially for me. When did my one jump happen (at the beginning of the trip or towards the end?).
Option 3: A more elaborate way to determine the association between jumping and mortality is to account for the richness of the exposures. Not just taking into account the specific days the jumps occurred, but how many jumps occurred each day and from which different altitudes these jumps took place. Then we can calculate the hazard of dying on a daily basis based on the previous 24 hours of jumps. Let’s go over this a bit further. The hazard on day 1 would be calculated using 3 people. Assuming we all survived, on day 2 the hazard would be calculated only among the people that jumped (2). On day 3, assuming we all survived, the hazard would be calculated again only among the people who jumped that day (2 jumps). On day 4, assuming we all survived the hazard would be calculated only among the people who jumped (1). If any of us were to arrive to the outcome during the observation, then that person would be removed from the analysis. This is the concept of time dependent exposures. You measure the outcome as the exposure occurs over time. This is in contrast to what we usually do in our hospital epi studies: exposure treated as binary variable (yes/no) or exposure treated as number of days exposed (9 or 3 or 1) or even as number of jumps performed. More concerning, the outcome on the latter examples is fixed towards the end of the observation rather than measured as time progresses.
Bringing it home: ANTIBIOTIC EXPOSURES. Antibiotics are such rich exposures. Think about it. They can be given during many different days throughout the hospital stay and there are many types of antibiotics, with various doses and routes. Outcome variables, such as acquiring a multidrug resistant organism or even developing an infection by this organism also vary in time during hospitalization. Is it reasonable to analyze all those antibiotic exposures clustered in time within a single day or even worse as binary variables? Is it optimal to fix the outcome variable as happening at the end of hospitalization? Intuitively, I would say no to both. There are a couple of examples in the ID literature that compare these analyses. One of them by my co-author Marc Bonten. However, specifically for antibiotics it is not fully clear to me if the associations found would justify the additional cost and time of obtaining all this rich information about exposures and outcomes (note: think about relooking at your cohort datasets using this method).
Let’s end this post here [so that I can take a quick nap before landing] and see the feedback I get with this example. If the feedback is good then I will explain the biases that can occur by not accounting for time in your analyses, and maybe go over delayed effect of antibiotics. In the meantime, I will be sipping a mojito with my hubby while enjoying Miami. Salud!
Tuesday, November 10, 2015
Start planning now for SHEA Spring Meeting 2016!
What follows is a guest post from the co-chairs of the SHEA Spring Meeting 2016 planning committee, Silvia Munoz-Price and Tom Talbot (I added the video at the end despite their protestations):
We want to encourage everyone interested in healthcare epidemiology and antibiotic stewardship to plan on attending the SHEA Spring Meeting 2016 in Atlanta. Titled “Science Guiding Prevention,” the planning committee has built on last year’s successful meeting to add more cutting edge, provocative, and diverse topics and speakers to advance key issues surrounding the field.
We want to encourage everyone interested in healthcare epidemiology and antibiotic stewardship to plan on attending the SHEA Spring Meeting 2016 in Atlanta. Titled “Science Guiding Prevention,” the planning committee has built on last year’s successful meeting to add more cutting edge, provocative, and diverse topics and speakers to advance key issues surrounding the field.
In addition to being an outstanding networking platform, this year we will also have:
- A new Antibiotic Stewardship track chaired by Drs. Sara Cosgrove and Kavita Trivedi designed to provide intensive training for directors of stewardship programs.
- Featured plenaries focused on partnership in preventing HAIs with leaders from a wide range of perspectives, including the media, quality improvement scientists, and patient safety advocates.
- The return of the Post-Acute Care/Long Term Care training course, which is now co-organized by SHEA, CDC, and AMDA and chaired by Dr. Nimalie Stone (CDC) and Dr. Robin Jump (representing AMDA). A certificate of participation will be given at the completion of the track (perfect for framing!!!).
- The tried and true SHEA-CDC Training Course in Healthcare Epidemiology, a jam-packed primer on important issues in healthcare epidemiology. Chaired by Dr. Sarah Haessler, this certificate course is perfect for persons new to the field as well as those needing a booster of healthcare epidemiology training.
- The SHEA Foundation Dinner (separate ticketed event) returns with featured speakers Dr. Julie Gerberding and Dr. David Henderson.
- Abstract presentations for targeted topics specific to healthcare epidemiology – mark your calendars for the January 29, 2016 submission deadline!
- The launching of the SHEA Mentorship Program.
- Finally, we’ve brought back the well-received "Women in Epi" networking event – this year, it will be an evening activity...with drinks instead of bagels!!!
We’re very excited about the program and hope to see you in Atlanta next spring!
Friday, April 10, 2015
SHEA 2015: *New* Post-Acute and Long-Term Care Track
In healthcare, we are in the process of transforming our approach from caring of an isolated individual to caring for the population as a whole. Similarly, we are slowly migrating from paying attention to single hospital encounters to focusing on the continuum of care of individuals. These facts are important in the fields of Infection Control and Hospital Epidemiology, as in order to control the spread of highly resistant pathogens we need to internalize that our hospital systems are interconnected through patient transfers. This is particularly evident in the interactions between acute care hospitals, long term care acute care hospitals (LTACHs), and nursing homes within regions. A few years ago, this interrelatedness was elegantly described by Won and colleagues in the midst of a regional outbreak of KPC Klebsiella pneumoniae in the Chicago area (Won et al CID 53: 532-540, figure below). Furthermore, controlling the spreadwithin the LTACH changed the whole transmission dynamic in the region (Munoz-Price Infect Control Hosp Epidemiol. 2010 Apr;31(4):341-7).
Research dealing with Infection Control practices in post-acute care settings is progressing, as recently described in this blog here, here and here. Given our interdependence, it is fundamental that providers in post-acute care --who deal directly with these infection control issues-- are knowledgeable and up to date. This year, SHEA’s Spring meeting will have a 2-day post-acute care track specifically designed to provide a general infection control overview to infection control personnel in post-acute care and LTACHs. The co-Director of this track, Dr. Nimalie Stone, is the Medical Epidemiologist for Long-term Care in the Division of Healthcare Quality Promotion (DHQP) at CDC. Additionally, we will have top notch speakers such as David Nace, Lona Mody, Curtis Donskey, among others. Upon completion, attendees will receive a certificate from SHEA.
A full description of the track can be found here. Participation and engagement of our post-acute care/LTACH colleagues is fundamental to succeed in our fight against hospital acquired infections.
We hope to meet you in Orlando!
Discounted registration ends April 17th (save $100), so register now!
Subscribe to:
Posts (Atom)
OSHA! OSHA! OSHA!
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...
-
Back on clinical service again and having more thoughts on poor hospital design. Last month I wondered why there were no stethoscope wipe...
-
Those that follow me on twitter or the blog have probably noticed my recent focus on trying to understand the emergence of compulsory influe...
-
REUTERS/Athit Perawongmetha With the assistance of a great supply management team, we have been able to outfit all of our clinical staff wit...

